Corcept Therapeutics
CORT
#2462
Rank
NZ$12.72 B
Marketcap
NZ$116.30
Share price
-2.09%
Change (1 day)
-14.20%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): NZ$0.19 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.96 Billion. In 2025 the company made an earning of NZ$81.88 Million a decrease over its 2024 earnings that were of NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.19 B141.73%
2025 NZ$81.88 M-67.29%
2024 NZ$0.25 B27.66%
2023 NZ$0.19 B-4.75%
2022 NZ$0.20 B-9.51%
2021 NZ$0.22 B-2.91%
2020 NZ$0.23 B14.87%
2019 NZ$0.20 B24.71%
2018 NZ$0.16 B69.32%
2017 NZ$96.61 M419.26%
2016 NZ$18.6 M-395.64%
2015 -NZ$6.3 Million-87.53%
2014 -NZ$50.49 Million-33.44%
2013 -NZ$75.86 Million
2011 -NZ$59.11 Million17.84%
2010 -NZ$50.16 Million35.5%
2009 -NZ$37.02 Million2.84%
2008 -NZ$36 Million60.81%
2007 -NZ$22.39 Million-52.14%
2006 -NZ$46.77 Million20.91%
2005 -NZ$38.68 Million31.87%
2004 -NZ$29.33 Million60.54%
2003 -NZ$18.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B 16,779.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$23.11 B 11,299.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.73 B 6,182.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.55 B 31,249.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.28 B 5,961.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.71 B 10,117.29%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$88.94 Million-143.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.14 B-28.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$79.81 M-60.63%๐Ÿ‡บ๐Ÿ‡ธ USA